Active Motif Acquires SwitchGear Genomics Further Expanding Gene Regulation Product Offerings
Published: Mar 22, 2013
“There is a strong scientific connection between epigenetics and gene regulation, and the combination of our technologies will create some very exciting possibilities for our customers,” said Joe Fernandez, CEO of Active Motif. “SwitchGear Genomics has a unique combination of expertise in computational regulatory element identification, experimental validation and data analysis that offers the scientist new and innovative high-throughput tools for studying regulatory element function across the genome.” He continued, “Our goal at Active Motif is to make cutting-edge research accessible to the wider life science community. Combining our innovative products with SwitchGear’s tools and expertise will give us the most comprehensive portfolio of gene regulation products available today.”
“The complementary strengths of the SwitchGear and Active Motif R&D teams put us in a unique position to support researchers across a broad spectrum of gene regulation research projects. This integration will enable Active Motif to expand its unique offering of research tools and genome-wide services for drug discovery,” added Theodore DeFrank, President of Active Motif.
About Active Motif
Active Motif, Inc. is dedicated to developing, manufacturing and delivering epigenetics-based research tools to analyze nuclear function. Its customers include life scientists from academic and government institutions; biotechnology and pharmaceutical companies; hospitals and reference laboratories. Active Motif operates globally through its corporate headquarters in Carlsbad, California; European headquarters in La Hulpe, Belgium; Asian headquarters in Tokyo, Japan and a worldwide network of sales and support offices. Active Motif applies a multi-disciplinary approach to create new and modify existing technologies to meet the current and future needs of life science researchers.